MST Access

Rosemary Cummins

Rosemary Cummins

Life Sciences & Plasma Products
Rosemary Cummins, is a rated equity research analyst with 20 experience specialising in Healthcare research at Citigroup and UBS; together with a focus on global plasma products. She has been a consultant to several Australian and international companies and has also led the Investor Relations function for ASX100 listed pharmacy distribution and hospital companies.

Recent Reports

Report Date
Ticker
Company
Sector
Report Name
Mar 30, 2021
PAR.AX
Paradigm Biopharmaceuticals Limited
Pharmaceuticals, Biotechnology & Life Sciences
Restricted Offering. Must be a subscriber to view
Mar 18, 2021
OPT.AX
Opthea Limited
Pharmaceuticals, Biotechnology & Life Sciences
Restricted Offering. Must be a subscriber to view
Mar 12, 2021
OSP.AX
Osprey Medical Inc
Health Care Equipment & Services
Restricted Offering. Must be a subscriber to view
Mar 03, 2021
OPT.AX
Opthea Limited
Pharmaceuticals, Biotechnology & Life Sciences
Restricted Offering. Must be a subscriber to view
Feb 18, 2021
NEU.AX
Neuren Pharmaceuticals Limited
Pharmaceuticals, Biotechnology & Life Sciences
Restricted Offering. Must be a subscriber to view
Feb 16, 2021
NEU.AX
Neuren Pharmaceuticals Limited
Pharmaceuticals, Biotechnology & Life Sciences
Restricted Offering. Must be a subscriber to view

Displaying : of 22 records
1 2 3 4 5 > >|

Stock Coverage